Literature DB >> 35584832

Sickle cell disease: an update.

Emma Conway O'Brien1, Sahla Ali2, Timothy Chevassut3.   

Abstract

Sickle cell disease is a common inherited disorder that is characterised by chronic haemolysis and vaso-occlusive episodes, resulting in severe pain and end-organ damage. The most frequent acute manifestation of sickle cell disease is a painful vaso-occlusive crisis, which can, in some cases, develop into a sickle chest crisis: a life-threatening complication of sickle cell disease that requires early recognition and prompt intervention to prevent progressive respiratory failure. In addition to the acute complications, patients with sickle cell disease are also at risk of a number of chronic complications that require multidisciplinary specialist input. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  haemoglobinopathy; sickle cell disease; sickle chest crisis; veno-occlusive crisis

Mesh:

Year:  2022        PMID: 35584832      PMCID: PMC9135093          DOI: 10.7861/clinmed.2022-0143

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  12 in total

1.  Guideline on the management of acute chest syndrome in sickle cell disease.

Authors:  Jo Howard; Nicholas Hart; Marilyn Roberts-Harewood; Michelle Cummins; Moji Awogbade; Bernard Davis
Journal:  Br J Haematol       Date:  2015-03-30       Impact factor: 6.998

Review 2.  Sickle cell disease.

Authors:  Russell E Ware; Mariane de Montalembert; Léon Tshilolo; Miguel R Abboud
Journal:  Lancet       Date:  2017-02-01       Impact factor: 79.321

Review 3.  Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.

Authors:  Amrana Qureshi; Banu Kaya; Shivan Pancham; Russell Keenan; Jeremy Anderson; Magbor Akanni; Jo Howard
Journal:  Br J Haematol       Date:  2018-05-06       Impact factor: 6.998

4.  Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Authors:  Marilyn J Telen
Journal:  Blood Adv       Date:  2020-07-28

5.  Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease.

Authors:  E P Vichinsky; L A Styles; L H Colangelo; E C Wright; O Castro; B Nickerson
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

Review 6.  The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management.

Authors:  Deepika S Darbari; Vivien A Sheehan; Samir K Ballas
Journal:  Eur J Haematol       Date:  2020-05-19       Impact factor: 2.997

7.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

8.  Definitions of the phenotypic manifestations of sickle cell disease.

Authors:  Samir K Ballas; Susan Lieff; Lennette J Benjamin; Carlton D Dampier; Matthew M Heeney; Carolyn Hoppe; Cage S Johnson; Zora R Rogers; Kim Smith-Whitley; Winfred C Wang; Marilyn J Telen
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

9.  Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease.

Authors:  Carlton Haywood; Sophie Lanzkron; Shawn Bediako; John J Strouse; Jennifer Haythornthwaite; C Patrick Carroll; Marie Diener-West; Gladys Onojobi; Mary Catherine Beach
Journal:  J Gen Intern Med       Date:  2014-09-10       Impact factor: 5.128

10.  Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.

Authors:  O S Platt; S H Orkin; G Dover; G P Beardsley; B Miller; D G Nathan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.